标题/作者	年份
Antidepressant drugs act by directly binding to TRKB neurotrophin receptors PC Casarotto, M Girych, SM Fred, V Kovaleva, R Moliner, G Enkavi, ... Cell 184 (5), 1299-1313. e19	2021
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective K Hashimoto Psychiatry and clinical neurosciences 73 (10), 613-627	2019
Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: an international expert opinion on the available evidence and implementation RS McIntyre, JD Rosenblat, CB Nemeroff, G Sanacora, JW Murrough, ... American Journal of Psychiatry 178 (5), 383-399	2021
Ketamine and depression: a narrative review A Corriger, G Pickering Drug design, development and therapy, 3051-3067	2019
Asymmetric organocatalysis: an enabling technology for medicinal chemistry B Han, XH He, YQ Liu, G He, C Peng, JL Li Chemical Society Reviews 50 (3), 1522-1586	2021
Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis A Bahji, GH Vazquez, CA Zarate Jr Journal of affective disorders 278, 542-555	2021
Intravenous arketamine for treatment-resistant depression: open-label pilot study GC Leal, ID Bandeira, FS Correia-Melo, M Telles, RP Mello, F Vieira, ... European archives of psychiatry and clinical neuroscience 271, 577-582	2021
Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites C Yang, J Yang, A Luo, K Hashimoto Translational psychiatry 9 (1), 280	2019
Antidepressant-relevant concentrations of the ketamine metabolite (2 R, 6 R)-hydroxynorketamine do not block NMDA receptor function EW Lumsden, TA Troppoli, SJ Myers, P Zanos, Y Aracava, J Kehr, J Lovett, ... Proceedings of the National Academy of Sciences 116 (11), 5160-5169	2019
Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments B Kadriu, L Musazzi, ID Henter, M Graves, M Popoli, CA Zarate Jr International Journal of Neuropsychopharmacology 22 (2), 119-135	2019
Molecular mechanisms of the rapid-acting and long-lasting antidepressant actions of (R)-ketamine K Hashimoto Biochemical Pharmacology 177, 113935	2020
(2R, 6R)-hydroxynorketamine exerts mGlu2 receptor-dependent antidepressant actions P Zanos, JN Highland, BW Stewart, P Georgiou, CE Jenne, J Lovett, ... Proceedings of the National Academy of Sciences 116 (13), 6441-6450	2019
A historical review of antidepressant effects of ketamine and its enantiomers Y Wei, L Chang, K Hashimoto Pharmacology Biochemistry and Behavior 190, 172870	2020
A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder A Feder, S Costi, SB Rutter, AB Collins, U Govindarajulu, MK Jha, ... American Journal of Psychiatry 178 (2), 193-202	2021
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: a randomized, double-blind, non-inferiority study FS Correia-Melo, GC Leal, F Vieira, AP Jesus-Nunes, RP Mello, ... Journal of affective disorders 264, 527-534	2020
Molecular pharmacology and neurobiology of rapid-acting antidepressants TD Gould, CA Zarate Jr, SM Thompson Annual review of pharmacology and toxicology 59, 213-236	2019
Comparison of antidepressant and side effects in mice after intranasal administration of (R, S)-ketamine,(R)-ketamine, and (S)-ketamine L Chang, K Zhang, Y Pu, Y Qu, SM Wang, Z Xiong, Q Ren, C Dong, ... Pharmacology biochemistry and Behavior 181, 53-59	2019
Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor Y Wei, L Chang, K Hashimoto Molecular Psychiatry 27 (1), 559-573	2022
Clinical pharmacology considerations in pain management in patients with advanced kidney failure SN Davison Clinical journal of the American Society of Nephrology: CJASN 14 (6), 917	2019
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability J Bonaventura, S Lam, M Carlton, MA Boehm, JL Gomez, O Solís, ... Molecular psychiatry 26 (11), 6704-6722	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。